TLS-related factors, especially their cellular components, were independently protective factors against tumor progression, indicating the potential predominance of humoral immunity in ALK+ tumors, which might help explain the poor efficacy of blocking the PD-1/PD-L1 pathway. This evidence concerns the gene CD274 and neoplasm.